Wang Wang is a Master's student in Biochemistry and Molecular Biology at the Medical College of Basic Sciences, Jiamusi University, China. He obtained his Bachelor of Science degree in Medical Laboratory Technology from Jiamusi University in 2024. His academic interests focus on cancer biology, cellular signalling pathways, and molecular mechanisms of drug resistance. As an emerging researcher, he has actively contributed to peer-reviewed publications in high-impact journals. He is a co-author of two recent studies investigating the effects of oleanolic acid on ageing and drug resistance in cancer, published in Molecules and the Journal of Clinical and Translational Hepatology. His current research continues to explore the therapeutic potential of bioactive compounds in hepatocellular carcinoma, combining both in vitro and in vivo approaches. Wang Wang is committed to advancing translational medicine through rigorous experimental work and interdisciplinary collaboration.

Hanting Zhou is a Research Assistant at The Chinese University of Hong Kong, Shenzhen. He holds an MPhil in Biological Sciences (2022–2024) from CUHK-Shenzhen and dual BSc degrees in Pharmaceutical Science from Queen’s University Belfast and China Medical University. His research focuses on molecular targeted therapy, RNA structural biology, and drug delivery systems. At CUHK-Shenzhen, he has designed programmable peptide nucleic acids (PNAs) for targeting viral RNA secondary structures and investigated SARS-CoV-2 programmed -1 ribosomal frameshifting using reporter systems, providing mechanistic insights applicable to tumour signalling research, including PI3K/AKT/mTOR pathways in liver cancer. At Queen’s University Belfast, he studied liver cancer metastasis through the TMEM16A-ROCK1 pathway, elucidating mechanisms relevant to the epithelial–mesenchymal transition and tumour microenvironment modulation. His early work at China Medical University involved the development of hydrophobic modified sodium alginate microspheres for drug delivery. Hanting has co-authored research in Cell Reports Physical Science and continues to contribute to RNA-targeting therapeutic strategies and APS-based cancer treatment studies.

Akanksha Sen is a PhD candidate in Nutrition at the University of Greenwich, where she investigates the antiepileptic effects of combining vitamin D with Ganoderma lucidum polysaccharides. Her research focuses on exploring calcium homeostasis and neuronal pathways associated with epilepsy under the guidance of Professor Shaobo Zhou, Programme Lead of BSc Human Nutrition and Health. She has experience as a researcher at the University of Kent, working on international industry-based projects in collaboration with Johnson & Johnson and MP Pharma International. Her work involved developing oleogel-based formulations for targeted brain delivery via non-parenteral routes. These involved cell and tissue culture, molecular biology, cytotoxicity assays, high-resolution microscopy, and novel methods to address the blood–brain barrier. Akanksha holds an MSc in Biotechnology from the University of Greenwich, where her project focused on recombinant toxins targeting potassium channels under Professor Saak V. Ovespian. She has contributed to multiple publications and has presented at national conferences, including events at the Alan Turing Institute and the Francis Crick Institute. Her work also includes contributions to developing laboratory methods and mentoring within research groups. Her current work sits at the intersection of molecular biology, neuroscience, and nutrition, with an emphasis on exploring non-conventional therapeutic approaches for neurological disorders.

Professor Pengxia Zhang is a Professor at the Medical College of Basic Sciences, Jiamusi University, China. She holds a PhD in Human Anatomy and Histology and Embryology from Bethune Medical College, Jilin University, an MSc in Pathology and Pathophysiology, and a Bachelor's degree in Clinical Medicine from Jiamusi Medical College. She has undertaken advanced research training at Peking University Health Science Center and completed postdoctoral work at Harbin Medical University. Her research focuses on cancer biology, drug resistance, tumour immunology, and molecular signalling pathways, with a particular interest in natural compounds such as oleanolic acid and their epigenetic and metabolic effects. Professor Zhang has led and co-authored numerous high-impact publications in journals such as Molecules, Cell Communication and Signaling, Journal of Translational Medicine, Cancer Science, and Cell Death & Disease. She has also contributed to the understanding of circular RNAs, tumour vaccines, ferroptosis, and immune checkpoint resistance. Recognised for her extensive contributions to translational medicine and oncology research, she collaborates across national and international institutions and plays a leading role in advancing integrative therapeutic strategies for hepatocellular and colorectal cancers.

Professor Linhong Yuan is Professor and Director of the Department of Nutrition and Food Hygiene at the School of Public Health, Capital Medical University, China. She earned her PhD in Nutrition and Food Hygiene from Harbin Medical University, with visiting research at Griffith University, Australia. Her research focuses on nutrition and cognitive ageing, particularly the effects of micronutrients, gene–diet interactions, and lipid metabolism on cognitive function and Alzheimer’s disease. Professor Yuan has led over 20 major projects, including multiple grants from the National Natural Science Foundation of China and municipal agencies, investigating the roles of DHA, vitamin A and E, lipid rafts, and gene polymorphisms in brain ageing. She has authored over 100 peer-reviewed publications in high-impact journals such as NPJ Science of Food, Journal of Nutrition Biochemistry, Food Frontiers, and Biomedicine & Pharmacotherapy. She collaborates internationally, including with researchers from the University of Greenwich, and serves as a recognised leader in cognitive nutrition. Her work has contributed to novel insights into dietary strategies for delaying age-related cognitive decline, combining public health relevance with molecular mechanisms.

Dr Shaobo Zhou is an Associate Professor in Nutrition and Health Science at the University of Greenwich, and Programme Leader for the BSc Human Nutrition and Health—an Association for Nutrition-accredited course. He completed his PhD in Nutrition at the Chinese National Key Department of Nutrition after receiving his MD training at Harbin Medical University and an MSc in zinc nutrition. Dr Zhou has received several recognitions, including awards from the Human Proteome Organisation for his work at King’s College London and from the Chinese Ministry of Health. He has completed projects on zinc nutrition, nutritional proteomics, and metabolomics funded by the Chinese National Natural Science Foundation, BBSRC, MRC, FSA, and the British Heart Foundation while he previously conducted research at the Chinese CDC, the University of Manchester, KCL, and Aberystwyth University. He is a Registered Nutritionist with the Association for Nutrition and serves as a member of the Specialty Committee of Brain Diseases under the World Federation of Chinese Medicine Societies. Dr Zhou has published over 120 papers and serves on editorial boards. He is a Fellow of both IFST and HEA. He has developed and led the BSc Food and Nutrition Science and MSc Food Security in Public Health programmes. His teaching disciplines include clinical and public health nutrition, as well as food and nutritional sciences. His research interests cover nutrition and ageing, cancer, diabetes, and sarcopenia.